Europe

Europe
#Arthritis #Biosimilars #Europe #NHS #Ulcerative colitis (UC)

Alvotech launches Simponi biosimilar in Europe 

Biotechnology company Alvotech has announced the European launch of its first-in-market biosimilar to Simponi (golimumab).  AVT05, known as Gobivaz, is a prefilled syringe and autoinjector used for the treatment of adults with rheumatoid arthritis, psoriatic arthritis and ulcerative colitis, as well as in children with ulcerative colitis. Gobivaz becomes the first marketed biosimilar to… Read More

#News

#Biotech #Europe #Investment #Start-ups #Venture funds

European biotech venture funds raise over €1.1 billion

Two European biotech venture funds have raised over €1.1 billion in capital in the last week.  Sofinnova Partners announced the close of Sofinnova Capital XI at €650 million, while Medicxi closed its Medicxi V fund at €500 million.  Sofinnova Capital XI attracted strong support from a global base of blue-chip… Read More

#Business & Investment #Editor's Choice #News #Start-up Zone

#Europe #European Union #Precision medicine

EU backs Swiss Rockets Serbia precision medicine hub

Biotech company Swiss Rockets Serbia has signed a Joint Declaration of Intent with the European Commission (DG ENEST) and the Development Agency of Serbia (RAS) to establish a regional centre of excellence for precision medicine.  The joint declaration announces the ambition of Swiss Rockets Serbia, a subsidiary of Swiss Rockets… Read More

#Business & Investment #News

European biotech
#Biologics / Biotechnology #Biotech #Europe #European Commission #European Union

Is the European Biotech Act a one-shot solution for the biotech sector?

For European Biotech Week, Diana Turner and Dr Claire Skentelbery, Director General, EuropaBio, examine the potential impact of the European Biotech Act. The European Biotech Act was first introduced by Ursula von der Leyen in 2024 in her paper ‘Europe’s Choice: Political Guidelines For The Next European Commission 2024−2029’. She… Read More

#Exclusive Content #Trends & Analysis

#Big pharma #Europe #Pharmaceutical industry #Switzerland #United States

Trump increases pressure on pharma and imposes new tariffs

US President Donald Trump has sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White House said on Thursday.  Trump signed an executive order in May demanding drugmakers cut US medicine prices to match… Read More

#Business & Investment #News #Trending News

Map of Europe
#Clinical trials #EFPIA #Europe #European Commission #European Union

Group warns European clinical research is at risk

A broad group of 14 organisations, working in the European clinical trial sector, have issued a warning that without urgent implementation of the Life Science Strategy (LSS), Europe’s clinical trial eco-system is in a perilous situation.  The stakeholders—including academic and industry sponsors, investigators, and professional societies—formed earlier this year to… Read More

#Business & Investment #News

European Commission President Ursula von der Leyen
#Biotech #Biotech hubs #Europe #European Commission #European Union #Market reporting

Can Europe take the lead on biotech?

With uncertainty across the global financial markets and research community, is it Europe’s time to take the lead on biotech? Diana Turner reports.  While biotech has so far been dominated by the US, since the inauguration of Donald Trump in January 2025, there has been considerable uncertainty, with significant cuts… Read More

#Exclusive Content #Market Reports #Trends & Analysis

#Drug discovery #Europe #European Commission #European Union

New DDW Highlights podcast: 14 July 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week our news highlights focus on the drug discovery in the European Union, including… Read More

#News

#Drug discovery #Europe #European Commission #European Union

This week in drug discovery (7-11 July) 

News round-up for 7-11 July by DDW Senior Digital Content Editor Diana Turner. This week our news highlights focus on the drug discovery in the European Union, including some new regulatory approvals from the European Commission, advancements from Netherlands-based argenx, a new PhD programme in Estonia, and Switzerland’s… Read More

#News

Double stranded DNA molecule with mutation in a gene
#Clinical trials #Cystic fibrosis #Drug delivery #Drug development #Europe #Kither Biotech

In Conversation With: Dimitrios Goundis, Kither Biotech

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dimitrios Goundis, CEO… Read More

#News

Stand Up for Science, US, March 2025
#Academic #Aix-Marseille Université #Europe #Institut Pasteur #Politics #United States #Vrije Universiteit Brussel

European universities offer scientific refuge to US researchers

Several prestigious European universities are opening their doors to American scientific researchers to provide refuge from what they call “attacks on scientific facts and against researchers”.  The Vrije Universiteit Brussel (VUB) is opening 12 postdoctoral positions for international researchers, which are open to American researchers… Read More

#News #Trending News

#Biotechnology #Europe #Fundraising

Europe’s largest biotech fund exceeds target with €165m

Sofinnova Biovelocita II has exceeded its target, successfully raising €165 million, with substantial backing from global pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures.   The milestone marks a significant expansion of Sofinnova Partners’ biotech acceleration strategy, extending beyond Italy to include France, the UK, and Denmark, with ambitions… Read More

#Business & Investment #News

EU flag
#EU Health Coalition #Europe #Life sciences

Life sciences must be a priority in the next EU budget, urges Coalition

For Europe to remain relevant and competitive, it must make health and the life sciences sector a central pillar of the next Multi Annual Financial Framework (MFF), according to the EU Health Coalition.  The Coalition emphasises that with a strategic focus on health in the MFF, Europe… Read More

#News

European map
#Europe #European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) #European Laboratory Day #Events #Lab automation

European Laboratory Day celebrates lab medicine contributions 

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) hosted European Laboratory Day on 5 November 2024. This annual event promotes activities that highlight the essential role of laboratory medicine in public health, individual patient care, education and research.  Healthcare is a top priority for Europe, as… Read More

#News

The European Medicines Agency in Amsterdam
#Drug discovery #Europe #France #Lithuania #Market reporting #Netherlands #Switzerland

Europe: Where is the drug discovery innovation?

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW's Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in… Read More

#Exclusive Content #Market Reports

AI brain
#Artificial intelligence (AI) #EFPIA #Europe #Regulatory #Research and development

EFPIA states AI rules must “enable not hinder” pharma R&D

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act. The AI Act, which bans certain AI applications that it… Read More

#Editor's Choice #News